IAM
SRRA

Integre Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Integre Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-578
Closed -$42K – 144
2016
Q3 		$42K Buy
+578
New +$44.7K 0.01% 131

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Integre Asset Management's SRRA Position: Q4 2016 in Review

Integre Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2016, closing a stake of 578 shares — an estimated $42K sold.

Integre Asset Management first reported a position in SRRA in Q3 2016 and held it in 1 quarter. The position peaked at $42K in Q3 2016. 36 funds tracked by Wall St. Rank hold SRRA as of Q4 2016.

  • Integre Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Integre Asset Management sold 578 Sierra Oncology, Inc. Common Stock shares in Q4 2016, an estimated $42K.
  • Integre Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
  • Integre Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $42K in Q3 2016.
  • 36 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2016.

Based on Integre Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.